Goodwin Procter advised Absci, while Latham & Watkins represented the underwriters in the offering. Absci Corporation (Absci), the synthetic biology company unlocking the potential of proteins...
Absci Corporation’s $200 Million Initial Public Offering
Zoom Video Communications’ $14.7 Billion Acquisition of Five9
Cooley LLP advised Zoom Video Communications, while Latham & Watkins LLP represented Five9 on the deal. Zoom Video Communications has entered into a definitive agreement to acquire Five9,...
LegalZoom’s Initial Public Offering
Latham & Watkins LLP represented the underwriters in the offering. LegalZoom.com, Inc., a leading online platform for legal and compliance solutions in the United States, has...
SentinelOne’s IPO and Concurrent Private Placement
Fenwick & West LLP advised SentinelOne on the deal, while Latham & Watkins LLP represents the underwriters. SentinelOne, an autonomous cybersecurity platform company, announced its initial public...
Thumbtack’s $275 Million Investment Round
Latham & Watkins LLP represented Thumbtack in the transaction. Thumbtack, the modern home management platform, has secured a US$275 million investment at a valuation of US$3.2 billion....
Janux Therapeutics’ $193.8 Million IPO
Wilson Sonsini Goodrich & Rosati advised Janux Therapeutics, Inc. on the deal, while Latham & Watkins LLP represented the underwriters. Janux Therapeutics, Inc., a biopharmaceutical company...
Skillz’s Acquisition of Aarki
Latham & Watkins LLP represented Skillz in the transaction. Skillz (NYSE: SKLZ), the leading mobile games platform bringing fair and fun competition to players worldwide, has entered...
Bright Machines’ Merger with SCVX
Willkie Farr & Gallagher LLP represented SCVX in the transaction, while Latham & Watkins LLP and Wolf Theiss represented Bright Machines. SCVX (NYSE: SCVX), a special...
Kajabi’s $550 Million Financing
Latham & Watkins LLP represented Kajabi and its Shareholders in the transaction. Kajabi, an e-commerce platform empowering entrepreneurs in the knowledge economy, has raised US$550 million after...
Rain Therapeutics’ $125 Million Initial Public Offering
Latham & Watkins LLP represented the underwriters in the offering. Rain Therapeutics Inc. (Rain), a clinical-stage company developing precision oncology therapeutics, executed its initial public offering...
Treace Medical Concepts’ $106.3 Million Initial Public Offering
Latham & Watkins LLP represented Treace Medical Concepts, Inc. in the offering. Treace Medical Concepts, Inc. (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a...
Biomea’s $153 Million Initial Public Offering
Latham & Watkins LLP represented Biomea Fusion, Inc. in the transaction. Biomea Fusion, Inc. (Nasdaq: BMEA) closed its initial public offering of 9 million shares of its...